Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Interim Management Statement

5 Oct 2009 07:00

RNS Number : 1888A
PZ CUSSONS PLC
05 October 2009
 



Monday 5 October 2009

PZ Cussons Plc

(the "Group")

Interim Management Statement

PZ Cussons Plc today issues the following interim management statement which covers the period 1st June 2009 to 4th October 2009, in advance of its Annual General Meeting, to be held at 12 noon today.

Overview of financial position and performance

The Board is pleased to announce that the performance of the Group during the period has been in line with management expectations. The financial position of the Group remains strong with cash generation during the period also in line with expectations.

Trading Update

During the last financial year, the Group's strategy and business model proved robust despite the 

global economic downturn, and this positive trading momentum has continued across the Group into the current financial year. Performance has been strong with an increase in profitability over the same period last year.

In Nigeria, the Group's largest market, the political environment has remained relatively stable whilst economically the country has continued to achieve positive GDP growth. The weakening of the exchange rate versus the US dollar has stabilised as a result of oil prices now rising again. In recent months, the strengthening of controls in the banking sector is viewed as positive for the long term economic health of the financial system. Our Personal Care, Home Care, Electricals and Nutrition businesses have all performed well during the period despite the temporary tightening of liquidity in the market following the new banking controls. Project Unity, the group's £39m investment in Nigeria's wider supply chain capability, remains on schedule with the new national distribution centre now operational. 

In the UK, the strategy of launching innovative new products tailored specifically for UK consumers continues to be successful across the brand range of Imperial Leather, Original Source, Carex, Charles Worthington, Morning Fresh and The Sanctuary. Performance has been strong and is benefiting from the new facility at Agecroft in Manchester which has been fully operational since February. The facility provides both low cost manufacturing and an integrated research and development and perfumery capability. 

Overall performance in the Group's other units has also been strong during the period.

 

Financial Position

The Group moved back into a net funds position at the end of the last financial year and cash generation during the current financial year remained strong with a continuing focus on minimising working capital levels across the Group following last year's significant reduction. Capital expenditure, of which Project Unity is the largest item, continues to be funded from operating cashflow.

Summary

The overall performance and position of the Group at the end of the period is in line with the Board's expectations.

Overall, we remain cautiously optimistic for the full year outturn despite the global economic picture 

remaining uncertain.

A further update on the Group's performance will be given in the interim financial statements for the six months to 30th November 2009, to be announced at the end of January 2010.

- Ends -

For further information contact:

PZ Cussons Plc

Tel: 0161 491 8000

Brandon Leigh / Graham Calder

Hogarth Partnership Limited Tel: 020 7357 9477

John Olsen / Sarah MacLeod/ Anna Keeble

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSCKBKKABDDAKK
Date   Source Headline
29th Nov 202111:25 amRNSDirector/PDMR Shareholding
25th Nov 20214:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:05 pmRNSAnnual General Meeting
9th Nov 20217:00 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPublication of Annual Report and notice of AGM
24th Sep 20219:00 amRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading Statement
22nd Sep 20217:00 amRNSFinal Results
13th Sep 20213:00 pmRNSAppointment of Non Executive Director
27th Jul 202111:00 amRNSDirector/PDMR Shareholding
5th Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTrading update
29th Jun 202110:45 amRNSNotice of pre-close trading update
25th Jun 20217:00 amRNSAppointment of Non Executive Director
27th Apr 20217:00 amRNSTrading Statement
25th Mar 20217:00 amRNSCapital Markets Day
22nd Mar 20211:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20215:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20219:00 amRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSHalf-year Report
1st Dec 20203:45 pmRNSDirector/PDMR Shareholding
26th Nov 20202:30 pmRNSResult of AGM
26th Nov 20207:00 amRNSDirectorate Change
23rd Oct 202012:00 pmRNSPublication of Annual Report / Notice of AGM
20th Oct 20201:00 pmRNSHolding(s) in Company
1st Oct 20208:38 amRNSCompletion of Nutricima disposal
28th Sep 20203:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:00 amRNSTrading Statement
23rd Sep 20207:00 amRNSBoard Change
23rd Sep 20207:00 amRNSFinal Results for the year ended 31 May 2020
14th Aug 20208:50 amRNSDirector Declaration
6th Jul 20209:05 amRNSDirector Declaration
30th Jun 20205:30 pmRNSDirector/PDMR Shareholding
19th Jun 20209:29 amRNSDirector/PDMR Shareholding
5th Jun 20202:15 pmRNSRevised reporting timetable
28th May 20201:01 pmRNSDirector/PDMR Shareholding
22nd May 202010:20 amRNSDirector Declaration
28th Apr 202011:33 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSTrading Update for the Third Quarter 2020
14th Apr 20204:15 pmRNSBoard Change
2nd Apr 20207:00 amRNSUpdate on Settlement Agreement with Former CEO
19th Mar 20207:00 amRNSAppointment of new Chief Executive Officer
19th Mar 20207:00 amRNSBoard changes
18th Mar 20207:00 amRNSSale of Nutricima and completion of Luksja sale
20th Feb 20207:00 amRNSHolding(s) in Company
28th Jan 20207:00 amRNSHalf-year Report
12th Dec 20197:00 amRNSDirectorate Change
12th Dec 20197:00 amRNSTrading Update
30th Oct 20197:00 amRNSAppointment of Non-executive Directors
30th Sep 201911:15 amRNSCompletion of Minerva sale

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.